Delivery Order SPE2DB22D2005-SPE2DB25FJRH2
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $11,345.16 to AmerisourceBergen Drug Corp for M-M-R II vaccine vials on August 6, 2025, with an ultimate completion date of August 7, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal healthcare vendor, serves as...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $28,758.80 to AmerisourceBergen Drug Corp for M-M-R II vaccine vials. This firm fixed price contract was competitively awarded with no set-aside designation and is scheduled for completion by August 20, 2025. AmerisourceBergen, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at approximately $113K to AmerisourceBergen Drug Corp for M-M-R II vaccine vials, with an ultimate completion date of September 15, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, was selected to...
- The Defense Logistics Agency awarded a delivery order valued at $4,356.33 to AmerisourceBergen Drug Corp for M-M-R II vaccine vials, with an ultimate completion date of August 18, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical vendor for federal...
- The Defense Logistics Agency awarded a delivery order valued at $11,473.57 to AmerisourceBergen Drug Corp for M-M-R II vaccine vials, with an ultimate completion date of August 7, 2025. This is a firm fixed price, competitively awarded delivery order with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical vendor for federal medical procurement, particularly supporting military and veteran...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $12,260.96 to AmerisourceBergen Drug Corp for M-M-R II vaccine vials, with a completion date of September 17, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and specifies Conshohocken, Pennsylvania as the place of performance, which is also AmerisourceBergen's corporate headquarters location. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC)...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $41,887.04 to AmerisourceBergen Drug Corp for M-M-R II vaccine vials, with a completion date of September 3, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the contractor's corporate headquarters in Conshohocken, Pennsylvania. The award represents a routine medical supply delivery under the DLA's pharmaceutical procurement operations supporting military and...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, for M-M-R II vaccine vials valued at $15,329.48. This firm fixed-price contract, awarded on August 21, 2025, with an ultimate completion date of August 22, 2025, represents a competitive award with no set-aside designation. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with...
- The Defense Logistics Agency awarded a delivery order valued at $33,522.33 to AmerisourceBergen Drug Corp for M-M-R II vaccine vials, with completion scheduled for September 2, 2025. The award, issued on August 29, 2025, represents a firm fixed-price, competitively awarded contract with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this work at its corporate office location. This delivery...
- The Defense Logistics Agency awarded a delivery order valued at $5,538.90 to AmerisourceBergen Drug Corp for M-M-R II vaccine vials, with an ultimate completion date of August 5, 2025. This is a firm fixed-price delivery order under a competitive, non-set-aside procurement. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical federal medical supply vendor that serves military and veteran healthcare systems through the DLA...
- SPE2DB22D2005Indefinite Delivery Contract
- SPE2DB22D2005-SPE2DB25FJRH2Delivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $26,085.80 to AmerisourceBergen Drug Corp for M-M-R II vaccine vials, with an ultimate completion date of August 13, 2025. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded to the prime contractor. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical procurement needs, particularly supporting military and veteran healthcare systems through the DLA's Medical Supply Chain. This delivery order operates under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. This comprehensive global pharmaceutical support vehicle enables the company to supply a vast range of pharmaceutical products and medical supplies, including vaccines, specialty medications, and other critical medical commodities to support military healthcare programs worldwide. The contract serves multiple customers including the Defense Health Agency and U.S. Coast Guard, positioning AmerisourceBergen as a key participant in the DLA's pharmaceutical prime vendor program.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $26.1k | 8/12/25 |